First in man: gene editing for the treatment of transthyretin amyloidosis

被引：0
|
作者：
Liuzzo, Giovanna [1 ]
Patrono, Carlo [2 ]
机构：
[1] Catholic Univ, Sch Med, Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc & Pulm Sci, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Catholic Univ, Sch Med, Fdn Policlin Univ A Gemelli IRCCS, Dept Pharmacol, Largo A Gemelli 8, I-00168 Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷 / 36期
关键词：
D O I：
10.1093/eurheartj/ehab542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3597 / 3598
页数：2
相关论文
共 50 条
  • [1] Gene Editing - A Cure for Transthyretin Amyloidosis?
    Maurer, Mathew S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 558 - 559
  • [2] Gene Editing to Treat Transthyretin Amyloidosis
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (04) : 845 - 845
  • [3] RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis
    Ioannou, Adam
    Fontana, Marianna
    Gillmore, Julian D.
    BIODRUGS, 2023, 37 (02) : 127 - 142
  • [4] RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis
    Adam Ioannou
    Marianna Fontana
    Julian D. Gillmore
    BioDrugs, 2023, 37 : 127 - 142
  • [5] CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
    Shahzad, Faizan
    Rehman, Mohammad Ebad Ur
    Basit, Jawad
    Saeed, Sajeel
    Abbas, Khawar
    Farhan, Muhammad
    ANNALS OF MEDICINE AND SURGERY, 2022, 83
  • [6] RNA-targeting and gene editing therapies for transthyretin amyloidosis
    Aimo, Alberto
    Castiglione, Vincenzo
    Rapezzi, Claudio
    Franzini, Maria
    Panichella, Giorgia
    Vergaro, Giuseppe
    Gillmore, Julian
    Fontana, Marianna
    Passino, Claudio
    Emdin, Michele
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (10) : 655 - 667
  • [7] RNA-targeting and gene editing therapies for transthyretin amyloidosis
    Alberto Aimo
    Vincenzo Castiglione
    Claudio Rapezzi
    Maria Franzini
    Giorgia Panichella
    Giuseppe Vergaro
    Julian Gillmore
    Marianna Fontana
    Claudio Passino
    Michele Emdin
    Nature Reviews Cardiology, 2022, 19 : 655 - 667
  • [8] CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
    Gillmore, Julian D.
    Gane, Ed
    Taubel, Jorg
    Kao, Justin
    Fontana, Marianna
    Maitland, Michael L.
    Seitzer, Jessica
    O'Connell, Daniel
    Walsh, Kathryn R.
    Wood, Kristy
    Phillips, Jonathan
    Xu, Yuanxin
    Amaral, Adam
    Boyd, Adam P.
    Cehelsky, Jeffrey E.
    McKee, Mark D.
    Schiermeier, Andrew
    Harari, Olivier
    Murphy, Andrew
    Kyratsous, Christos A.
    Zambrowicz, Brian
    Soltys, Randy
    Gutstein, David E.
    Leonard, John
    Sepp-Lorenzino, Laura
    Lebwohl, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 493 - 502
  • [9] CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
    Rim, John Hoon
    Gopalappa, Ramu
    Gee, Heon Yung
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18): : 1722 - 1722
  • [10] Treatment of transthyretin cardiac amyloidosis
    Bampatsias, Dimitrios
    Wardhere, Abdirahman
    Maurer, Mathew S.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (05) : 407 - 416
12345